Norsk Patenttidende nr 05/07 - Patentstyret
Norsk Patenttidende nr 05/07 - Patentstyret
Norsk Patenttidende nr 05/07 - Patentstyret
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
nye patentsøknader 20<strong>07</strong>.01.29 - <strong>nr</strong> <strong>05</strong>/<strong>07</strong><br />
(51) Klasse : A61K<br />
(21) Søknads<strong>nr</strong> : 20066<strong>07</strong>7<br />
(22) Inng.dag : 2006.12.29<br />
(30) Prioritet : 2004.06.03, US, 60/576,825<br />
2004.09.02, US, 60/606,790<br />
(86) Int.inng.dag : 20<strong>05</strong>.06.01<br />
(86) Int.søknads<strong>nr</strong> : PCT/US<strong>05</strong>/19<strong>05</strong>3<br />
(24) Løpedag 20<strong>05</strong>.06.01<br />
(71) Søker<br />
SmithKline Beecham (Cork) Ltd , Curraghbinny,<br />
CARRIGALINE, COUNTY CORK, IE<br />
(74) Fullmektig<br />
Bryn Aarflot AS , Postboks 449 Sentrum, 0104 OSLO, NO<br />
(72) Oppfinner<br />
Mark S Berger, c/o GlaxoSmithKline, Upper Providence, P<br />
O Box 5089, COLLEGEVILLE, PA19426, US<br />
Iman El-Hariry, c/o GlaxoSmithKline, Research and<br />
Development, 891-995 Greenford Road, GREENFORD<br />
MIDDLESEX, UB60HE, GB<br />
Tona Morgan Gilmer, c/o GlaxoSmithKline, P O Box<br />
13398, RESEARCH TRIANGLE, NC27709, US<br />
Arundathy Nirmalini Pandite, c/o GlaxoSmithKline, P O Box<br />
13398, RESEARCH TRIANGLE, NC27709, US<br />
David Rusnak, c/o GlaxoSmithKline, P O Box 13398,<br />
RESEARCH TRIANGLE, NC27709, US<br />
Neil L Spector, c/o GlaxoSmithKline, P O Box 13398,<br />
RESEARCH TRIANGLE, NC27709, US<br />
(54) Benevnelse<br />
Behandlingsmetode for cancer<br />
(51) Klasse : A61K<br />
(21) Søknads<strong>nr</strong> : 20066<strong>07</strong>9<br />
(22) Inng.dag : 2006.12.29<br />
(30) Prioritet : 2004.06.04, US, 60/577,337<br />
(86) Int.inng.dag : 20<strong>05</strong>.06.03<br />
(86) Int.søknads<strong>nr</strong> : PCT/US<strong>05</strong>/19568<br />
(24) Løpedag 20<strong>05</strong>.06.03<br />
(71) Søker<br />
SmithKline Beecham (Cork) Ltd , Curraghbinny,<br />
CARRIGALINE, COUNTY CORK, IE<br />
(74) Fullmektig<br />
Bryn Aarflot AS , Postboks 449 Sentrum, 0104 OSLO, NO<br />
(72) Oppfinner<br />
Mark S Berger, c/o GlaxoSmithKline, Upper Providence, P<br />
O Box 5089, COLLEGEVILLE, PA19426, US<br />
Tona Morgan Gilmer, c/o GlaxoSmithKline, P O Box<br />
13398, RESEARCH TRIANGLE, NC27709, US<br />
Arundathy Nirmalini Pandite, c/o GlaxoSmithKline, P O Box<br />
13398, RESEARCH TRIANGLE, NC27709, US<br />
(54) Benevnelse<br />
Behandlingsmetode for cancer<br />
(51) Klasse : A61K<br />
(21) Søknads<strong>nr</strong> : 20066081<br />
(22) Inng.dag : 2006.12.29<br />
(30) Prioritet : 2004.06.04, EP, 04291393<br />
(86) Int.inng.dag : 20<strong>05</strong>.06.02<br />
(86) Int.søknads<strong>nr</strong> : PCT/GB<strong>05</strong>/02215<br />
(24) Løpedag 20<strong>05</strong>.06.02<br />
(71) Søker<br />
AstraZeneca AB , 15185 SÖDERTÄLJE, SE<br />
(74) Fullmektig<br />
Bryn Aarflot AS , Postboks 449 Sentrum, 0104 OSLO, NO<br />
(72) Oppfinner<br />
Bernard Christophe Barlaam, c/o AstraZeneca, ZI La<br />
Pompelle, BP 1<strong>05</strong>0, REIMS CEDEX 2, 51689, FR<br />
Jason Grant Kettle, c/o AstraZeneca R&D Alderley,<br />
Alderley Park, MACCLESFIELD, CHESHIRE, SK104TG,<br />
GB<br />
Robert Hugh Bradbury, c/o AstraZeneca R&D Alderley,<br />
Alderley Park, MACCLESFIELD, CHESHIRE, SK104TG,<br />
GB<br />
James Stewart Scott, c/o AstraZeneca R & D Alderley,<br />
Alderley Park, MACCLESFIELD, CHESHIRE, SK104TG,<br />
GB<br />
(54) Benevnelse<br />
Kinazolinderivater som erbB-reseptortyrosinkinaser<br />
(51) Klasse : A61K<br />
(21) Søknads<strong>nr</strong> : 20<strong>07</strong>0026<br />
(22) Inng.dag : 20<strong>07</strong>.01.02<br />
(30) Prioritet : 2004.06.03, US, 10/860,201<br />
(86) Int.inng.dag : 20<strong>05</strong>.<strong>05</strong>.30<br />
(86) Int.søknads<strong>nr</strong> : PCT/SE<strong>05</strong>/00806<br />
(24) Løpedag 20<strong>05</strong>.<strong>05</strong>.30<br />
(71) Søker<br />
Biogaia AB , Box 3242, 10364 STOCKHOLM, SE<br />
(74) Fullmektig<br />
Tandbergs Patentkontor AS , Postboks 7085 Majorstua,<br />
0306 OSLO, NO<br />
(72) Oppfinner<br />
Elisabeth Sjöberg, Kyrkoled 8, LUND, 22731, SE<br />
Bo Mollstam, Cedeflychtsvägen 12, LERUM, 44331, SE<br />
Bengt Björksten, Västmannagatan 12, STOCKHOLM,<br />
11124, SE<br />
(54) Benevnelse<br />
Fremgangsmåte for forbedret brystmelkmating for<br />
reduksjon av risikoen for allergi<br />
(51) Klasse : A61K<br />
(21) Søknads<strong>nr</strong> : 20066080<br />
(22) Inng.dag : 2006.12.29<br />
(30) Prioritet : 2004.06.03, US, 60/576,503<br />
(86) Int.inng.dag : 20<strong>05</strong>.<strong>05</strong>.25<br />
(86) Int.søknads<strong>nr</strong> : PCT/EP<strong>05</strong>/<strong>05</strong>639<br />
(24) Løpedag 20<strong>05</strong>.<strong>05</strong>.25<br />
(71) Søker<br />
F Hoffmann-La Roche AG , Grenzacherstrasse 124, 4<strong>07</strong>0<br />
BASEL, CH<br />
(74) Fullmektig<br />
Bryn Aarflot AS , Postboks 449 Sentrum, 0104 OSLO, NO<br />
(72) Oppfinner<br />
Brian Higgins, 69-14 Utopia Parkway, FRESH MEADOWS,<br />
NY11365, US<br />
Kenneth Kolinsky, 22 Vreeland Avenue, BLOOMINGDALE,<br />
NJ<strong>07</strong>403, US<br />
Jianping Chen, 10 Kerri Lane, LINCOLN PARK, NJ<strong>07</strong>035,<br />
US<br />
(54) Benevnelse<br />
Behandling med irinotecan (CPT-11) og en AGFR-inhibitor<br />
6